James B. Tananbaum - 23 Dec 2021 Form 4/A - Amendment Insider Report for PARDES BIOSCIENCES, INC.

Role: Director, 10%+ Owner
Signature: /s/ Elizabeth Lacy, Attorney-in-Fact for James B. Tananbaum
Issuer symbol: N/A
Transactions as of: 23 Dec 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 10 Jun 2022, 16:17:45 UTC
Date Of Original Report: 28 Dec 2021
Previous filing: 23 Dec 2021
Next filing: 10 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRDS	Stock Option (right to buy)	Award	$0	+75,000		$0.000000	75,000	23 Dec 2021	Common Stock	75,000	$9.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest in substantially equal monthly installments over three years, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.

Remarks:

This amendment amends the Form 4 filed on December 28, 2021 solely to correct Table II, Column 5 which inadvertently reported the 75,000 stock options as having been "Disposed" as opposed to the correct designation of "Acquired."